News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chrontech Pharma AB: Interim Report ChronTech Pharma January-March 2010


4/28/2010 9:49:12 AM

STOCKHOLM--(BUSINESS WIRE)--ChronTech Pharma AB (STO:CTEC): Research and development costs amounted to SEK 1.8 (1.1) m.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES